AmbrogioLab
@AmbrogioLab
Followers
408
Following
1K
Media
7
Statuses
166
Official account of Chiara Ambrogio´s Laboratory, https://t.co/zg15HkbZoy
Joined December 2020
RT @obenaufa: Pls RT: Are you studying the multifaceted MAPK pathway? We would love to hear about your exciting research! .Abstract Deadlin….
0
13
0
RT @CrozrX: 📖 🎯.A new book!.RAS Drug Discovery.•.Past, Present and Future.🔸️.A comprehensive overview of the state-of-the-art medicinal che….
0
10
0
RT @AACR_CEO: I am excited for the next three days of @theNCI's RAS Initiative Symposium 2024. Today, @NCIDirector Rathmell and AACR Past P….
0
9
0
RT @obenaufa: Excited to co-organize the virtual @EACRnews @Boehringer Conference: Drugging & Regulating the MAP Kinase Pathway! Submit an….
0
20
0
Our latest publication online now! @NatureComms .Amazing team work @lab_santamaria @MJNokin @BiagioRicciutMD @DrMarkAwad @NadalErnest @cereda_lab.
0
6
35
Our PREDICT project is among the 2024 ERC Proof of Concept grants! @ERC_Research #ERCPoC.
📣 Out now! First results of the 2024 ERC Proof of Concept call. 100 grants – each worth €150,000 – will help ERC grantees to bridge the gap between the discoveries stemming from their frontier research and their practical application. More 👉
4
4
36
0
8
0
RT @EACRnews: There are just a few more days left to register for our upcoming Early-Career Researchers' Conference, happening online 25-26….
0
14
0
RT @MariluCasini: Stunning results from @CanaudLab who just presented their case study that led to an FDA-approved drug. Thanks @unito for….
0
1
0
RT @EACRnews: There's not long left to wait until the EACR Congress comes to the Netherlands in June! ☀️. Don't miss the opportunity to tak….
0
7
0
RT @CD_AACR: Read the #CancerHallmarks Perspective—.Piecing the Puzzle Together. @AmbrogioLab @MariaPAlcolea @gemma….
0
17
0
RT @inoagrafioti: Can you believe we got to fund 9 LS1 @ERC_research grants?!?🤩HUGE congratulations to:@clausen_lab, @Archaellum,T. Hoppe @….
0
3
0
RT @CarmenMeccaPhD: @BiagioRicciutMD from @DanaFarber is presenting today at #AACR2024 section 41 poster 18 new data on wild type KRAS amp….
0
4
0
RT @gerlach_d: Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy | Nature #AACR24
0
8
0
RT @Aiims1742: Out in @Nature concurrent with #AACR24.Two papers on biochemistry and preclinical characterization of Revolution Medicines’….
0
79
0
RT @InnovOncology: They define a future of cancer team science adopting “radical collaboration”—in which six “Hallmarks of Cancer Collabora….
0
6
0
RT @imedverse: Opinions of early- and mid-career investigators on the key challenges and open questions related to each of the fourteen Can….
0
4
0